Losartan Recall Expanded
WASHINGTON, D.C. — The Food and Drug Administration said that the recall of Losartan drugs must be expanded after detection of the carcinogen NMBA. The FDA, in its announcement, said the Torrent Pharmaceuticals manufacturers the recall high blood pressure medication. Fox News said that there are only small amounts of the carcinogen … [Read more...] about Losartan Recall Expanded
Teva Pulls Recalls More Losartan
UNITED STATES – Teva Pharmaceuticals has pulled several lots of Losartan off the market due to contamination with a probable carcinogenic substance. Testing of six bulk lots of the drug showed that it contained unsafe levels of a substance that can potentially cause cancer. Losartan is a widely prescribed drug for high blood … [Read more...] about Teva Pulls Recalls More Losartan
Possible Carcinogen Found in Losartan
WASHINGTON, D.C. — Legacy Pharmaceutical Packing, the packing company for losartan high blood pressure medication, along with the U.S. Food and Drug Administration announced another recall for the drug because the pill contained a possible carcinogenic substance according to the U.S.A Today. The notice of the recall was made public … [Read more...] about Possible Carcinogen Found in Losartan
